By Dr Louise Emmett

Journal articles

Long GV; Atkinson VG; Lo S; Sandhu SK; Brown M; Gonzalez M; Guminski A; Scolyer RA; Emmett L; Menzies AM; McArthur GA, 2019, 'Long-term outcomes from the randomized phase II study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 brain collaboration (ABC)', Annals of Oncology, 30, pp. v534 - v534, http://dx.doi.org/10.1093/annonc/mdz255.001

Lieng H; Hayden AJ; Christie DRH; Davis BJ; Eade TN; Emmett L; Holt T; Hruby G; Pryor D; Shakespeare TP; Sidhom M; Skala M; Wiltshire K; Yaxley J; Kneebone A, 2018, 'Radiotherapy for recurrent prostate cancer: 2018 Recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group', Radiotherapy and Oncology, 129, pp. 377 - 386, http://dx.doi.org/10.1016/j.radonc.2018.06.027

Tan AC; Emmett L; Lo S; Liu V; Kapoor R; Carlino MS; Guminski AD; Long GV; Menzies AM, 2018, 'FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma', Annals of Oncology, 29, pp. 2115 - 2120, http://dx.doi.org/10.1093/annonc/mdy330

Hruby G; Eade T; Emmett L; Ho B; Hsiao E; Schembri G; Guo L; Kwong C; Hunter J; Byrne K; Kneebone A, 2018, '⁶⁸Ga-PSMA-PET/CT staging prior to definitive radiation treatment for prostate cancer', Asia-Pacific Journal of Clinical Oncology, 14, pp. 343 - 346, http://dx.doi.org/10.1111/ajco.12872

Hope TA; Afshar-Oromieh A; Eiber M; Emmett L; Fendler WP; Lawhn-Heath C; Rowe SP, 2018, 'Imaging prostate cancer with prostate-specific membrane antigen PET/CT and PET/MRI: Current and future applications', American Journal of Roentgenology, 211, pp. 286 - 294, http://dx.doi.org/10.2214/AJR.18.19957

Byrne K; Eade T; Kneebone A; Guo L; Hsiao E; Schembri G; Kwong C; Hunter J; Emmett L; Hruby G, 2018, 'Delineating sites of failure following post-prostatectomy radiation treatment using ⁶⁸Ga-PSMA-PET', Radiotherapy and Oncology, 126, pp. 244 - 248, http://dx.doi.org/10.1016/j.radonc.2017.10.022

Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, 38, pp. 159 - 162, http://dx.doi.org/10.1007/s10875-018-0477-z

Roach PJ; Francis R; Emmett L; Hsiao E; Kneebone A; Hruby G; Eade T; Nguyen QA; Thompson BD; Cusick T; McCarthy M; Tang C; Ho B; Stricker PD; Scott AM, 2018, 'The impact of ⁶⁸ Ga-PSMA PET/CT on management intent in prostate cancer: Results of an australian prospective multicenter study', Journal of Nuclear Medicine, 59, pp. 82 - 88, http://dx.doi.org/10.2967/jnumed.117.197160

, 2018, '2018 CUA Abstracts.', Can Urol Assoc J, 12, pp. S51 - S136, https://www.ncbi.nlm.nih.gov/pubmed/29877793

Pouliot F; Bauman G; Chua S; Davis I; Hicks R; Metser U; Punwani S; Scott A; Weickhardt A; Emmett L, 2018, 'PD37-02 A PROSPECTIVE MULTICENTER STUDY COMPARING MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING (MP-MRI), F-18 FLUORO-METHYL-CHOLINE (FCH) AND GA-68 HBED-CC- (PSMA) POSITRON EMISSION TOMOGRAPHY IN PATIENTS BEING CONSIDERED FOR SALVAGE RADIATION THERAPY FOR BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY', Journal of Urology, 199, http://dx.doi.org/10.1016/j.juro.2018.02.1737

Emmett L; Metzer U; Bauman G; Pouliot F; Hicks R; Chua S; Davis I; Punwani S; Weikhardt A; Scott A, 2018, 'Prospective, multinational comparison of magnetic resonance imaging (mp-MRI and WB–MRI) F-18 fluorocholine (FCH) and Ga-68 PSMA in high risk men being considered for salvage radiation treatment for biochemical failure post radical prostatectomy', European Urology Supplements, 17, pp. e583 - e583, http://dx.doi.org/10.1016/s1569-9056(18)31246-6

Emmett L; Nandurkar R; Van Leeuwen P; Woo H; Kooner R; Ende D; O’Neill G; Yuen C; Ho B; Nguyen Q; Hickey A; Stricker P, 2018, 'Staging with Ga-68 HBED-CC-Glu-NH-CO-NH-Lys (Ahx) PSMA-11 PET CT (PSMA) prior to radical prostatectomy has high predictive value in assessing biochemical response to surgery', European Urology Supplements, 17, pp. e1903 - e1903, http://dx.doi.org/10.1016/s1569-9056(18)32310-8

Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L, 2017, 'Frusemide aids diagnostic interpretation of ⁶⁸Ga-PSMA positron emission tomography/CT in men with prostate cancer', Journal of Medical Imaging and Radiation Oncology, 61, pp. 739 - 744, http://dx.doi.org/10.1111/1754-9485.12625

Emmett L; Van Leeuwen PJ; Nandurkar R; Scheltema MJ; Cusick T; Hruby G; Kneebone A; Eade T; Fogarty G; Jagavkar R; Nguyen Q; Ho B; Joshua AM; Stricker P, 2017, 'Treatment outcomes from ⁶⁸Ga-PSMA PET/CT-informed salvage radiation treatment in men with rising PSA after radical prostatectomy: Prognostic value of a negative PSMA PET', Journal of Nuclear Medicine, 58, pp. 1972 - 1976, http://dx.doi.org/10.2967/jnumed.117.196683

Siriwardana A; Thompson J; van Leeuwen PJ; Doig S; Kalsbeek A; Emmett L; Delprado W; Wong D; Samaratunga H; Haynes AM; Coughlin G; Stricker P, 2017, 'Initial multicentre experience of ⁶⁸gallium-PSMA PET/CT guided robot-assisted salvage lymphadenectomy: acceptable safety profile but oncological benefit appears limited', BJU International, 120, pp. 673 - 681, http://dx.doi.org/10.1111/bju.13919

Fendler WP; Calais J; Allen-Auerbach M; Bluemel C; Eberhardt N; Emmett L; Gupta P; Hartenbach M; Hope TA; Okamoto S; Helmut Pfob C; Pöppel TD; Rischpler C; Schwarzenböck S; Stebner V; Unterrainer M; Zacho HD; Maurer T; Gratzke C; Crispin A; Czernin J; Herrmann K; Eiber M, 2017, '⁶⁸Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: An international multicenter prospective study', Journal of Nuclear Medicine, 58, pp. 1617 - 1623, http://dx.doi.org/10.2967/jnumed.117.190827

Fanti S; Minozzi S; Morigi JJ; Giesel F; Ceci F; Uprimny C; Hofman MS; Eiber M; Schwarzenbock S; Castellucci P; Bellisario C; Chauvie S; Bergesio F; Emmett L; Haberkorn U; Virgolini I; Schwaiger M; Hicks RJ; Krause BJ; Chiti A, 2017, 'Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions', European Journal of Nuclear Medicine and Molecular Imaging, 44, pp. 1622 - 1635, http://dx.doi.org/10.1007/s00259-017-3725-1

Calopedos RJS; Chalasani V; Asher R; Emmett L; Woo HH, 2017, 'Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: A systematic review and meta-analysis', Prostate Cancer and Prostatic Diseases, 20, pp. 352 - 360, http://dx.doi.org/10.1038/pcan.2017.23

Stodell M; Thompson JF; Emmett L; Uren RF; Kapoor R; Saw RPM, 2017, 'Melanoma patient imaging in the era of effective systemic therapies', European Journal of Surgical Oncology, 43, pp. 1517 - 1527, http://dx.doi.org/10.1016/j.ejso.2017.05.014

Long GV; Atkinson V; Menzies AM; Lo S; Guminski AD; Brown MP; Gonzalez MM; Diamante K; Sandhu SK; Scolyer RA; Emmett L; McArthur GA, 2017, 'A randomized phase II study of nivolumab or nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases (mets): The Anti-PD1 Brain Collaboration (ABC).', Journal of Clinical Oncology, 35, pp. 9508 - 9508, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9508

Emmett L; Willowson K; Violet J; Shin J; Blanksby A; Lee J, 2017, 'Lutetium ¹⁷⁷ PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy', Journal of Medical Radiation Sciences, 64, pp. 52 - 60, http://dx.doi.org/10.1002/jmrs.227

van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD, 2017, 'Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer', BJU International, 119, pp. 209 - 215, http://dx.doi.org/10.1111/bju.13540

Hruby G; Eade T; Kneebone A; Emmett L; Guo L; Ho B; Hsiao E; Schembri G; Hunter J; Kwong C, 2017, 'Delineating biochemical failure with ⁶⁸Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer', Radiotherapy and Oncology, 122, pp. 99 - 102, http://dx.doi.org/10.1016/j.radonc.2016.11.023

Holtkamp LHJ; Read RL; Emmett L; Thompson JF; Nieweg OE, 2017, 'Futility of imaging to stage melanoma patients with a positive sentinel lymph node', Melanoma Research, 27, pp. 457 - 462, http://dx.doi.org/10.1097/CMR.0000000000000362

Gonzalez M; Menzies AM; Saw R; Thompson JF; Spillane AJ; Howle J; Nieweg O; Shannon K; Ch'Ng S; Stretch JF; Carlino MS; Guminski A; Emmett L; Rizos H; Scolyer RA; Long GV, 2017, 'A Phase II, Randomised, Open Label Study of Neoadjuvant Pembrolizumab with/without Dabrafenib and Trametinib (D+T) in BRAF V600 Mutant Resectable Stage IIIB/C/D Melanoma (NeoTrio Trial)', Annals of Oncology, 28, pp. v445 - v445, http://dx.doi.org/10.1093/annonc/mdx377.041

Menzies AM; Gonzalez M; Guminski A; Nieweg O; Shannon K; Thompson JF; Kefford R; Ch'Ng S; Stretch J; Spillane AJ; Lee J; Lee H; Kapoor R; Emmett L; Rizos H; Saw RP; Scolyer RA; Long GV, 2017, 'Phase 2 study of neoadjuvant dabrafenib + trametinib (D+T) for resectable stage IIIB/C BRAF V600 mutant melanoma', Annals of Oncology, 28, pp. v432 - v432, http://dx.doi.org/10.1093/annonc/mdx377.007

Bhatia KD; Ambati C; Dhaliwal R; Paschkewitz R; Hsu E; Ho B; Young A; Emmett L, 2016, 'SPECT-CT/VQ versus CTPA for diagnosing pulmonary embolus and other lung pathology: Pre-existing lung disease should not be a contraindication', Journal of Medical Imaging and Radiation Oncology, 60, pp. 492 - 497, http://dx.doi.org/10.1111/1754-9485.12471

Kanthan GL; Izard MA; Emmett L; Hsiao E; Schembri GP, 2016, 'Schwannoma showing avid uptake on 68Ga-PSMA-HBED-CC PET/CT', Clinical Nuclear Medicine, 41, pp. 703 - 704, http://dx.doi.org/10.1097/RLU.0000000000001281

Long GV; Atkinson V; Menzies AM; Guminski AD; Sandhu SK; Brown MP; Liaw T; Gonzalez M; Davison J; Paton EJ; Scolyer RA; Emmett L; McArthur GA, 2016, 'A randomized phase 2 study of nivolumab and nivolumab combined with ipilimumab in patients (pts) with melanoma brain metastases: The Anti-PD1 Brain Collaboration (ABC Study).', Journal of Clinical Oncology, 34, pp. TPS9591 - TPS9591, http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps9591

Lee P; Bova R; Schofield L; Bryant W; Dieckmann W; Slattery A; Govendir MA; Emmett L; Greenfield JR, 2016, 'Brown Adipose Tissue Exhibits a Glucose-Responsive Thermogenic Biorhythm in Humans', Cell Metabolism, 23, pp. 602 - 609, http://dx.doi.org/10.1016/j.cmet.2016.02.007

Tang R; Wang JTY; Wang L; Le K; Huang Y; Hickey AJ; Emmett L, 2016, 'Impact of patient preparation on the diagnostic performance of ¹⁸F-FDG PET in cardiac sarcoidosis a systematic review and meta-analysis', Clinical Nuclear Medicine, 41, pp. e327 - e339, http://dx.doi.org/10.1097/RLU.0000000000001063

Van Leeuwen PJ; Emmett L; Hruby G; Kneebone A; Stricker P, 2016, '548 68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment', European Urology Supplements, 15, pp. e548 - e548, http://dx.doi.org/10.1016/s1569-9056(16)60550-x

Van Leeuwen P; Emmett L; Ho B; Delprado W; Stricker P, 2016, '559 Prospective evaluation of 68Ga-PSMA positron emission tomography/computerized tomography for preoperative lymph node staging in prostate cancer', European Urology Supplements, 15, pp. e559 - e559, http://dx.doi.org/10.1016/s1569-9056(16)60561-4

Emmett L, 2015, '68Ga-PSMA has high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.', BJU International

Morigi JJ; Stricker PD; Van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L, 2015, 'Prospective Comparison of ¹⁸F-Fluoromethylcholine Versus ⁶⁸Ga-PSMA PET/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy', Journal of Nuclear Medicine, 56, pp. 1185 - 1190, http://dx.doi.org/10.2967/jnumed.115.160382

Wang LW; Omari A; Emmett L; Jansz PC; Huilgol R; Rainer S; Subbiah RN, 2015, 'Granulomatous sarcoid aortitis: A serious complication of a well-known multisystem disease', The Lancet, 385, pp. 2014, http://dx.doi.org/10.1016/S0140-6736(15)60649-3

Emmett L, 2015, 'Prognostic and diagnostic implications of nonperfusion data on SPECT myocardial perfusion imaging', Current Cardiovascular Imaging Reports, 8, pp. 1 - 9, http://dx.doi.org/10.1007/s12410-014-9307-8

Sasson S; Smith S; Sewell WA; Morey A; Danta M; Emmett L; Kelleher AD; Fay K; Phan T, 2014, 'MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY', INTERNAL MEDICINE JOURNAL, 44, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Naehrig D; Uren RF; Emmett L; Ioannou K; Hong A; Wratten C; Thompson JF; Hruby G, 2014, 'Sentinel lymph node mapping for defining site and extent of elective radiotherapy management of regional nodes in Merkel cell carcinoma: A pilot case series', Journal of Medical Imaging and Radiation Oncology, 58, pp. 353 - 359, http://dx.doi.org/10.1111/1754-9485.12180

Brungs D; Sze V; Emmett L; Epstein RJ, 2013, 'Complete Radiologic Response of Bulky Cerebral Metastases From Newly Diagnosed HER2-Positive Breast Cancer to Upfront Trastuzumab-Based Chemotherapy.', World J Oncol, 4, pp. 122 - 125, http://dx.doi.org/10.4021/wjon639w

Emmett L; Ho B, 2012, 'Imaging for melanoma and non-melanoma skin cancers', Cancer Forum, 36

Emmett L; Ng A; Ha L; Russo R; Mansberg R; Zhao W; Chow SV; Kritharides L, 2012, 'Comparative assessment of rest and post-stress left ventricular volumes and left ventricular ejection fraction on gated myocardial perfusion imaging (MPI) and echocardiography in patients with transient ischaemic dilation on adenosine MPI: Myocardial stunning or subendocardial hypoperfusion?', Journal of Nuclear Cardiology, 19, pp. 735 - 742, http://dx.doi.org/10.1007/s12350-012-9571-4

Emmett L, 2012, 'Disparate physical measurements of the left ventricle on concurrent Adenosine Myocardial Perfusion Imaging (MPI) and Echocardiography in patients with Transient ischaemic dilation and stunning of the left ventricle on MPI.', Journal of Nuclear Cardiology

Girgis CM; Wong T; Ngu MC; Emmett L; Archer KA; Chen RC; Seibel MJ, 2011, 'Hypophosphataemic osteomalacia in patients on adefovir dipivoxil', Journal of Clinical Gastroenterology, 45, pp. 468 - 473, http://dx.doi.org/10.1097/MCG.0b013e3181e12ed3

Russo RR; Emmett L; Mansberg R; Fung KC, 2010, 'Severe ischaemia on SPECT myocardial perfusion imaging secondary to microvascular dysfunction and apical hypertrophic cardiomyopathy', Clinical Nuclear Medicine, 35, pp. 937 - 940, http://dx.doi.org/10.1097/RLU.0b013e3181f9de3c

Chung SCS; Peters MJ; Chen S; Emmett L; Ing AJ, 2010, 'Effect of unilateral endobronchial valve insertion on pulmonary ventilation and perfusion: A pilot study', Respirology, 15, pp. 1079 - 1083, http://dx.doi.org/10.1111/j.1440-1843.2010.01815.x

Russo RR; Ha L; Emmett L; Magee M; Mansberg R, 2010, 'Progressive visual loss due to obstruction of an optic nerve sheath fenestration demonstrated on SPECT/CT radionuclide cisternography', Clinical Nuclear Medicine, 35, pp. 208 - 210, http://dx.doi.org/10.1097/RLU.0b013e3181cc647a

Wong T; Girgis CM; Ngu MC; Chen RCY; Emmett L; Archer KA; Seibel MJ, 2010, 'Hypophosphatemic osteomalacia after low-dose adefovir dipivoxil therapy for hepatitis B', Journal of Clinical Endocrinology and Metabolism, 95, pp. 479 - 480, http://dx.doi.org/10.1210/jc.2009-2051

Seccombe LM; Chung SCS; Jenkins CR; Frater CJ; Mackey DWJ; Pearson MA; Emmett L; Peters MJ, 2010, 'Lung perfusion and chest wall configuration is altered by glossopharyngeal breathing', European Respiratory Journal, 36, pp. 151 - 156, http://dx.doi.org/10.1183/09031936.00163209

Russo RR; Lee A; Mansberg R; Emmett L, 2009, 'Hypertrophic pulmonary osteoarthropathy demonstrated on SPECT/CT', Clinical Nuclear Medicine, 34, pp. 628 - 631, http://dx.doi.org/10.1097/RLU.0b013e3181b06c9c

Back to profile page